POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions

Recruiting now · Phase 2

Conditions studied: Prostate

In brief

The goal of this study to determine if using the (18)F-rhPSMA-7.3 PET-CT scan can improve the ability to spot serious prostate cancer in patients who have uncertain MRI results. These uncertain results include MRI results that showed a PIRADS 2 or PIRADS 3 area on the prostate. The investigators want to find out if this new test is better to detect prostate cancer than just doing a biopsy based on MRI alone.

Key facts

Study ID
NCT07220720
Run by
University of Florida
People needed
30
Starts
2025-11-04
Expected to finish
2032-11-15
Last updated by the study team
2026-04-13

Who can join

Age: 18 and older, up to 100. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.